FDA
Eribulin Mesylate
The FDA lists this product in 10 strengths and forms.
Composition
- Active ingredients
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA218281-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA217085-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA218142-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionThis page
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA218047-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA214850-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA217250-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA217473-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA219054-001 · Prescription
- ERIBULIN MESYLATE 1MG/2ML (0.5MG/ML) · SolutionANDA218743-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA214310.
At a glance
- Brand name
- Eribulin Mesylate
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Sandoz
- Status
- Prescription
- FDA approval
- 9 Jun 2025
- Application
- ANDA214310-001